-
1
-
-
0025849053
-
Measurement of prostate specific antigen in serum as a screening test for prostate cancer
-
Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, and Andriole GL: Measurement of prostate specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324: 1156-1161, 1991.
-
(1991)
N Engl J Med
, vol.324
, pp. 1156-1161
-
-
Catalona, W.J.1
Smith, D.S.2
Ratliff, T.L.3
Dodds, K.M.4
Coplen, D.E.5
Yuan, J.J.6
Petros, J.A.7
Andriole, G.L.8
-
2
-
-
0026583502
-
Serum prostate specific antigen as a pre-screening test for prostate cancer
-
Labrie F, Dupont A, Suburu R, Cusan L, Tremblay M, Gomez JL, and Edmond I: Serum prostate specific antigen as a pre-screening test for prostate cancer. J Urol 147: 846-852, 1992.
-
(1992)
J Urol
, vol.147
, pp. 846-852
-
-
Labrie, F.1
Dupont, A.2
Suburu, R.3
Cusan, L.4
Tremblay, M.5
Gomez, J.L.6
Edmond, I.7
-
3
-
-
0026514819
-
Screening for prostate carcinoma with prostate specific antigen
-
Brawer MK, Chetner MP, Beatie I, Buchner DM, Vesella RL, and Lange PH: Screening for prostate carcinoma with prostate specific antigen. J Urol, part 2, 147: 846-852, 1992.
-
(1992)
J Urol, Part 2
, vol.147
, pp. 846-852
-
-
Brawer, M.K.1
Chetner, M.P.2
Beatie, I.3
Buchner, D.M.4
Vesella, R.L.5
Lange, P.H.6
-
4
-
-
0027226031
-
Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening
-
Catalona WJ, Smith DS, Ratliff TL, and Basler IW: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270: 948-954, 1993.
-
(1993)
JAMA
, vol.270
, pp. 948-954
-
-
Catalona, W.J.1
Smith, D.S.2
Ratliff, T.L.3
Basler, I.W.4
-
5
-
-
0028787810
-
Comparison of different prostate specific antigen cutpoints for early detection of prostate cancer: Results of a large screening study
-
Reissigl A, Pointner J, Horninger W, Ennemoser O, Strasser H, Klocker H, and Bartsch G.: Comparison of different prostate specific antigen cutpoints for early detection of prostate cancer: results of a large screening study. Urology 46: 662-665, 1995.
-
(1995)
Urology
, vol.46
, pp. 662-665
-
-
Reissigl, A.1
Pointner, J.2
Horninger, W.3
Ennemoser, O.4
Strasser, H.5
Klocker, H.6
Bartsch, G.7
-
6
-
-
0026077430
-
Prostate-specific antigen in serum occurs predominantly in complex with α-1-antichymotrypsin
-
Lilja H, Christensson A, Dahlen W, Matikainen MT, Nilsson I, Petersson K, and Lövgren T: Prostate-specific antigen in serum occurs predominantly in complex with α-1-antichymotrypsin. Clin Chem 37: 1618-1625, 1991.
-
(1991)
Clin Chem
, vol.37
, pp. 1618-1625
-
-
Lilja, H.1
Christensson, A.2
Dahlen, W.3
Matikainen, M.T.4
Nilsson, I.5
Petersson, K.6
Lövgren, T.7
-
7
-
-
0026027671
-
1 antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostate cancer: Assay of the complex improves clinical sensitivity for cancer
-
1 antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostate cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 51: 222-226, 1991.
-
(1991)
Cancer Res
, vol.51
, pp. 222-226
-
-
Stenman, W.H.1
Leinonen, I.2
Alfthon, H.3
Ramikko, S.4
Tukkanen, K.5
Alfthan, O.6
-
9
-
-
0027243748
-
1-antichymotrypsin as an indicator of prostate cancer
-
1-antichymotrypsin as an indicator of prostate cancer. J Urol 150: 100-105, 1993.
-
(1993)
J Urol
, vol.150
, pp. 100-105
-
-
Christensson, A.1
Bjork, T.2
Nilsson, O.3
Dahlen, U.4
Matikainen, M.T.5
Cockett, A.T.6
Abrahamsson, P.A.7
Lilja, H.8
-
10
-
-
0028800933
-
Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening
-
Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, and Nadler RB: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 274: 1214-1220, 1995.
-
(1995)
JAMA
, vol.274
, pp. 1214-1220
-
-
Catalona, W.J.1
Smith, D.S.2
Wolfert, R.L.3
Wang, T.J.4
Rittenhouse, H.G.5
Ratliff, T.L.6
Nadler, R.B.7
-
11
-
-
0029121452
-
Free, complexed and total serum prostate specific antigen: The establishment of appropriate reference ranges for their concentrations and ratios
-
Oesterling JE, Jacobsen SJ, Klee GG, Petersson K, Piironen T, Abrahamsson PA, Stenman U-H, Dowell B, Lövgren T, and Lilja H: Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios. J Urol 154: 1090-1095, 1995.
-
(1995)
J Urol
, vol.154
, pp. 1090-1095
-
-
Oesterling, J.E.1
Jacobsen, S.J.2
Klee, G.G.3
Petersson, K.4
Piironen, T.5
Abrahamsson, P.A.6
Stenman, U.-H.7
Dowell, B.8
Lövgren, T.9
Lilja, H.10
-
12
-
-
0029933686
-
Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer
-
Chen Y-T, Luderer AA, Thiel RP, Carlson G, Cuny CL, and Soriano TF: Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer. Urology 47: 518-524, 1996.
-
(1996)
Urology
, vol.47
, pp. 518-524
-
-
Chen, Y.-T.1
Luderer, A.A.2
Thiel, R.P.3
Carlson, G.4
Cuny, C.L.5
Soriano, T.F.6
-
13
-
-
0029997813
-
Clinical significance of the determination of noncomplexed prostate-specific antigen as a marker for prostate carcinoma
-
Froschermaier SE, Pilarsky CP, and Wirth MP: Clinical significance of the determination of noncomplexed prostate-specific antigen as a marker for prostate carcinoma. Urology 47: 525-528, 1996.
-
(1996)
Urology
, vol.47
, pp. 525-528
-
-
Froschermaier, S.E.1
Pilarsky, C.P.2
Wirth, M.P.3
-
14
-
-
0343811453
-
Improvement of prostate cancer screening by determination of the ratio free/total prostate-specific antigen in addition to prostate specific antigen levels
-
in press
-
Reissigl A, Klocker H, Pointner J, Ennemoser O, Falk M, and Bartsch G: Improvement of prostate cancer screening by determination of the ratio free/total prostate-specific antigen in addition to prostate specific antigen levels. Prostate, in press.
-
Prostate
-
-
Reissigl, A.1
Klocker, H.2
Pointner, J.3
Ennemoser, O.4
Falk, M.5
Bartsch, G.6
-
15
-
-
0027244140
-
Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges
-
Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, and Lieber MM: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 270: 860-864, 1993.
-
(1993)
JAMA
, vol.270
, pp. 860-864
-
-
Oesterling, J.E.1
Jacobsen, S.J.2
Chute, C.G.3
Guess, H.A.4
Girman, C.J.5
Panser, L.A.6
Lieber, M.M.7
-
16
-
-
0031020854
-
Frequency and clinical significance of transition zone cancer in prostate cancer screening
-
in press
-
Reissigl A, Pointner J, Strasser H, Ennemoser O, Klocker H, and Bartsch G: Frequency and clinical significance of transition zone cancer in prostate cancer screening. Prostate, in press.
-
Prostate
-
-
Reissigl, A.1
Pointner, J.2
Strasser, H.3
Ennemoser, O.4
Klocker, H.5
Bartsch, G.6
-
17
-
-
0028939781
-
A comparison of prostate-specific antigen, prostate specific membrane antigen, and LNCaP based enzyme-linked immonosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement
-
Murphy GP, Holmes EH, Boynton AL, Kenny GM, Ostenson RC, Erickson SJ, and Barren RJ: A comparison of prostate-specific antigen, prostate specific membrane antigen, and LNCaP based enzyme-linked immonosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement. Prostate 26: 164-168, 1995.
-
(1995)
Prostate
, vol.26
, pp. 164-168
-
-
Murphy, G.P.1
Holmes, E.H.2
Boynton, A.L.3
Kenny, G.M.4
Ostenson, R.C.5
Erickson, S.J.6
Barren, R.J.7
-
18
-
-
0025869392
-
Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate
-
Oesterling JE: Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907-923, 1991.
-
(1991)
J Urol
, vol.145
, pp. 907-923
-
-
Oesterling, J.E.1
-
19
-
-
0019122410
-
Quantification of prostate-specific antigen in serum by sensitive enzyme immunoassay
-
Kuriyama M, Wang MC, Papsidero LD, Killian CS, Shimano T, Valenzela L, Nishiura T, Murphy GP, and Chu TM: Quantification of prostate-specific antigen in serum by sensitive enzyme immunoassay. Cancer Res 40: 4658, 1980.
-
(1980)
Cancer Res
, vol.40
, pp. 4658
-
-
Kuriyama, M.1
Wang, M.C.2
Papsidero, L.D.3
Killian, C.S.4
Shimano, T.5
Valenzela, L.6
Nishiura, T.7
Murphy, G.P.8
Chu, T.M.9
-
20
-
-
0001682829
-
Increased specificity of prostate-specific antigen in serum
-
Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse MG, and Ratliff TL: Increased specificity of prostate-specific antigen in serum. J Urol 153(suppl): 312A, 1995
-
(1995)
J Urol
, vol.153
, Issue.SUPPL.
-
-
Catalona, W.J.1
Smith, D.S.2
Wolfert, R.L.3
Wang, T.J.4
Rittenhouse, M.G.5
Ratliff, T.L.6
|